Unique clinical presentations and follow-up outcomes from experience with congenital disorders of glycosylation: PMM2-PGM1-DPAGT1-MPI-POMT2-B3GALNT2-DPM1-SRD5A3-CDG

被引:1
作者
Celik, Merve Yoldas [1 ]
Yazici, Havva [2 ]
Erdem, Fehime [2 ]
Yanbolu, Ayse Yuksel [2 ]
Aykut, Ayca [3 ]
Durmaz, Asude [3 ]
Zeybek, Selcan [4 ]
Canda, Ebru [2 ]
Ucar, Sema Kalkan [2 ]
Coker, Mahmut [2 ]
机构
[1] Ege Univ, Fac Med, Dept Pediat Metab, TR-35040 Izmir, Turkiye
[2] Ege Univ, Dept Pediat, Div Pediat Metab & Nutr, Fac Med, Izmir, Turkiye
[3] Ege Univ, Dept Genet, Fac Med, Izmir, Turkiye
[4] Tinaztepe Univ, Fac Med, Dept Genet, Izmir, Turkiye
关键词
B3GALNT2; CDG; DPAGT1; DPM1; POMT2; SRD5A3; O-GLYCOSYLATION; MUTATIONS; DIAGNOSIS; HYPOGLYCOSYLATION; MANAGEMENT; SRD5A3-CDG; PATIENT; PROTEIN; CDG;
D O I
10.1515/jpem-2022-0641
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Congenital Glycosylation Disorders (CDG) are a large group of inherited metabolic diseases with multi-organ involvement. Herein, we aimed to expand the clinical characteristics of patients with CDG based on our experience with diagnoses and follow-up of CDG patients from different subtypes.Methods: The clinical and laboratory findings from the last 15 years were reviewed retrospectively in Ege University Child Metabolism and Nutrition Department.Results: There were 8 (57.2 %) females and 6 (42.8 %) males. Diagnoses of the patients were PMM2-CDG (n=4), PGM1-CDG (n=2), DPAGT1-CDG (n=2), SRD5A3-CDG (n=2), MPI-CDG (n=1), POMT2-CDG (n=1), B3GALNT2-CDG (n=1), DPM1-CDG (n=1). The clinical findings of the patients were dysmorphia (85.7 %), developmental delay (85.7 %), intellectual disability (85.7 %), ocular abnormalities (64.2 %), skeletal malformations (64.2 %), failure to thrive (57.1 %), microcephaly (57.1 %), hepatomegaly (35.7 %), hearing loss (35.7 %), seizures (28.5 %), gastrointestinal symptoms (21.4 %), endocrine abnormalities (21.4 %), and cardiac abnormalities (7.1 %). Laboratory findings were abnormal TIEF (92.8 %), abnormal liver enzymes (64.2 %), decreased protein C (64.2 %), decreased antithrombin III (64.2 %), decreased protein S (42.8 %), hypogammaglobulinemia (35.7 %), cerebellar hypoplasia (28.5 %), CK elevation (7.1 %), and hypoglycemia (7.1 %).Conclusions: This study contributes to the literature by sharing our ultra-rare DPM1-CDG case with less than 20 cases in the literature and expanding the clinical and molecular characteristics of other CDG patients. Hyperinsulinemic hypoglycemia, short stature, hypothyroidism, growth hormone deficiency, hypogammaglobulinemia, pericardial effusion, elevated CK, congenital myasthenia, and anorectal malformation were unique findings that were observed. Cerebello-ocular findings accompanying multi-organ involvement were an essential clue for a possible CDG.
引用
收藏
页码:530 / 538
页数:9
相关论文
共 43 条
[11]   Long term outcome ofMPI-CDGpatients on D-mannose therapy [J].
Girard, Muriel ;
Douillard, Claire ;
Debray, Dominique ;
Lacaille, Florence ;
Schiff, Manuel ;
Vuillaumier-Barrot, Sandrine ;
Dupre, Thierry ;
Fabre, Monique ;
Damaj, Lena ;
Kuster, Alice ;
Torre, Stephanie ;
Mention, Karine ;
McLin, Valerie ;
Dobbelaere, Dries ;
Borgel, Delphine ;
Bauchard, Eric ;
Seta, Nathalie ;
Bruneel, Arnaud ;
De Lonlay, Pascale .
JOURNAL OF INHERITED METABOLIC DISEASE, 2020, 43 (06) :1360-1369
[12]   A compound heterozygous mutation in DPAGT1 results in a congenital disorder of glycosylation with a relatively mild phenotype [J].
Iqbal, Zafar ;
Shahzad, Mohsin ;
Vissers, Lisenka E. L. M. ;
van Scherpenzeel, Monique ;
Gilissen, Christian ;
Razzaq, Attia ;
Zahoor, Muhammad Yasir ;
Khan, Shaheen N. ;
Kleefstra, Tjitske ;
Veltman, Joris A. ;
de Brouwer, Arjan P. M. ;
Lefeber, Dirk J. ;
van Bokhoven, Hans ;
Riazuddin, Sheikh .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2013, 21 (08) :844-849
[13]   FAMILIAL PSYCHOMOTOR RETARDATION WITH MARKEDLY FLUCTUATING SERUM PROLACTIN, FSH AND GH LEVELS, PARTIAL TBG-DEFICIENCY, INCREASED SERUM ARYLSULFATASE-A AND INCREASED CSF PROTEIN - NEW SYNDROME [J].
JAEKEN, J ;
VANDERSCHUERENLODEWEYCKX, M ;
CASAER, P ;
SNOECK, L ;
CORBEEL, L ;
EGGERMONT, E ;
EECKELS, R .
PEDIATRIC RESEARCH, 1980, 14 (02) :179-179
[14]   SRD5A3 defective congenital disorder of glycosylation: clinical utility gene card [J].
Jaeken, Jaak ;
Lefeber, Dirk J. ;
Matthijs, Gert .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2020, 28 (09) :1297-1300
[15]   CDG nomenclature: Time for a change! [J].
Jaeken, Jaak ;
Hennet, Thierry ;
Matthijs, Gert ;
Freeze, Hudson H. .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2009, 1792 (09) :825-826
[16]   SRD5A3-CDG: Emerging Phenotypic Features of an Ultrarare CDG Subtype [J].
Kamarus Jaman, Nazreen ;
Rehsi, Preeya ;
Henderson, Robert H. ;
Loebel, Ulrike ;
Mankad, Kshitij ;
Grunewald, Stephanie .
FRONTIERS IN GENETICS, 2021, 12
[17]   SRD5A3-CDG: A patient with a novel mutation [J].
Kasapkara, C. S. ;
Tumer, L. ;
Ezgu, F. S. ;
Hasanoglu, A. ;
Race, V. ;
Matthijs, G. ;
Jaeken, J. .
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2012, 16 (05) :554-556
[18]   Failure of short-term mannose therapy of patients with carbohydrate-deficient glycoprotein syndrome type 1A [J].
Kjaergaard, S ;
Kristiansson, B ;
Stibler, H ;
Freeze, HH ;
Schwartz, M ;
Martinsson, T ;
Skovby, F .
ACTA PAEDIATRICA, 1998, 87 (08) :884-888
[19]   Congenital Disorder of Glycosylation: Clinical and Molecular Characteristics of 9 Patients from Turkey [J].
Kose, Melis ;
Kose, Engin ;
Kagnici, Mehtap ;
Tekin, Hande Gazeteci ;
Ozen, Burcin ;
Ozdemir, Taha Resid ;
Kirbiyik, Ozgur ;
Onay, Huseyin ;
Yilmaz, Unsal ;
Unalp, Aycan .
IZMIR DR BEHCET UZ COCUK HASTANESI DERGISI, 2020, 10 (03) :267-273
[20]   Case Report: DPM1-CDG: Novel Variant with Severe Phenotype and Literature Review [J].
Lausmann, Hanna ;
Zacharias, Martin ;
Neuhann, Teresa M. ;
Locher, Melanie K. ;
Schettler, Karl F. .
FRONTIERS IN GENETICS, 2022, 13